Highbridge Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,200
Closed -$122K 1806
2016
Q4
$122K Buy
+11,200
New +$149K ﹤0.01% 1188

Other funds holding NPTN

Highbridge Capital Management's NPTN Position: Q2 2017 in Review

Highbridge Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2017, closing a stake of 181,906 shares — an estimated $1.64M sold.

Highbridge Capital Management first reported a position in NPTN in Q1 2015 and held it in 8 quarters. The position peaked at $1.64M in Q1 2017. 101 funds tracked by Wall St. Rank hold NPTN as of Q2 2017.

  • Highbridge Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 181,906 NEOPHOTONICS CORP shares in Q2 2017, an estimated $1.64M.
  • Highbridge Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 8 quarters.
  • Highbridge Capital Management's NEOPHOTONICS CORP position peaked at $1.64M in Q1 2017.
  • 101 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.